Telemedicine is effective in treating both Type 1 and Type 2 diabetes, according to researchers at the University Hospital in Tours and several other French research centers. Their work was reported on in August 2018 in the Journal of Telemedicine and E-Health.
As if they were a single, sizable study with 6,170 participants, the researchers combined 42 trials of the technique and performed an analysis on them…
- a total of 34 studies used devices for telemonitoring blood sugar levels while the other
- 8 used teleconsultation.
When compared to those who received standard care, the HbA1c levels of the participants who used telemedicine decreased more noticeably, and the difference was more pronounced in participants with Type 2 diabetes than in those with Type 1 diabetes. Participants who were 41 to 50 years old improved significantly more than participants who were younger, and telemedicine programs lasting longer than six months reduced HbA1c levels more than shorter programs.
Another investigation, reported on in January 2018 in the Journal of Telemedicine and Telecare, showed telemedicine to be effective at preventing low blood sugar levels as well. In their analysis, scientists from Huzhou University and a number of other Chinese research centers combined 14 studies. In 1324 diabetic participants, they discovered that telemedicine cut the risk of low blood sugar by an average of 58 percent.
Type 2 diabetes and gestational diabetes patients should be concerned about obesity. According to an article published in the Journal of Telemedicine and Telecare in Telemedicine has been found to be useful for the management of body mass index (BMI) by researchers at the National Yang-Ming University Hospital in Yilan and other research institutions in Taiwan as of January 2018. There were a total of 25 trials with 6253 participants. When treating those, telemedicine reduced BMI more effectively than standard care alone…
- obesity alone,
- being overweight,
- having diabetes, or
- high blood pressure.
Continuing their care for at least six months and follow-up care afterward, was also helpful
Telemedicine also has its place in Gestational or pregnancy-related diabetes. In August of 2018, the journal Diabetes Research and Clinical Practice reported on a study performed at the Australian research facilities include the University of Melbourne and others. There were 95 pregnant women in total who had been given a diagnosis of gestational diabetes…
- 61 received telemedical care as well as the usual care, while
- 34 received general attention only.
Both groups’ healthcare expenses were equal. The women receiving telemedical care required fewer adjustments to their insulin dosage and achieved their desired HbA1c levels in an average of 4.3 weeks as opposed to the women receiving standard care, who did so in an average of 7.6 weeks.